DK0451237T3 - Farmaceutiske præparater - Google Patents

Farmaceutiske præparater

Info

Publication number
DK0451237T3
DK0451237T3 DK90915084.9T DK90915084T DK0451237T3 DK 0451237 T3 DK0451237 T3 DK 0451237T3 DK 90915084 T DK90915084 T DK 90915084T DK 0451237 T3 DK0451237 T3 DK 0451237T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
preparations
androgen
liposomes
preferably used
Prior art date
Application number
DK90915084.9T
Other languages
Danish (da)
English (en)
Inventor
Georg Roessling
Andreas Sachse
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0451237T3 publication Critical patent/DK0451237T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90915084.9T 1989-10-27 1990-10-10 Farmaceutiske præparater DK0451237T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3936328A DE3936328A1 (de) 1989-10-27 1989-10-27 Pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
DK0451237T3 true DK0451237T3 (da) 1994-07-18

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90915084.9T DK0451237T3 (da) 1989-10-27 1990-10-10 Farmaceutiske præparater

Country Status (15)

Country Link
US (1) US5723146A (pt)
EP (1) EP0451237B1 (pt)
JP (1) JP3011762B2 (pt)
AT (1) ATE103804T1 (pt)
AU (1) AU6553790A (pt)
CA (1) CA2028629C (pt)
DE (2) DE3936328A1 (pt)
DK (1) DK0451237T3 (pt)
FI (1) FI913100A0 (pt)
GR (1) GR900100772A (pt)
HU (1) HU215127B (pt)
IE (1) IE903859A1 (pt)
NO (1) NO912435L (pt)
PT (1) PT95697B (pt)
WO (1) WO1991006284A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
EP1316317A1 (fr) * 2001-11-30 2003-06-04 University of Liege Associations hydrosolubles à base de cyprotérone et/ou d'un ester de celle-ci, leurs préparations et leurs utilisations
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
EP1784164A4 (en) * 2004-09-03 2008-07-09 Piedmont Pharmaceuticals Llc PROCESS FOR TRANSMEMBRANE TREATMENT AND PREVENTION OF OTITIS MEDIA
ZA200803370B (en) * 2005-09-26 2009-09-30 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into middle ear
US20080269187A1 (en) * 2005-09-26 2008-10-30 Campbell William R Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear
DE102006062120A1 (de) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
BRPI0812264B1 (pt) * 2007-05-29 2016-01-26 Pola Chem Ind Inc vesícula, e, preparação externa para pele
US8288342B2 (en) * 2008-10-10 2012-10-16 Teva Women's Health, Inc. Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
ITMI20110644A1 (it) * 2011-04-14 2012-10-15 Giuliani Spa Sistema per il rilascio prolungato di agenti cosmetici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
GB2112730B (en) * 1981-09-30 1985-12-18 Nat Res Dev Encapsulated particles
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
WO1986001402A1 (en) * 1984-09-05 1986-03-13 Schering Aktiengesellschaft Means for handling androgenization phenomena and use of antiandrogens for the production thereof
IT1199625B (it) * 1985-01-08 1988-12-30 Finchimica Srl Uso terapeutico del ciproterone acetato
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
IE903859A1 (en) 1991-05-08
NO912435D0 (no) 1991-06-21
HU907959D0 (en) 1991-11-28
HUT57590A (en) 1991-12-30
AU6553790A (en) 1991-05-02
CA2028629C (en) 2000-12-19
ATE103804T1 (de) 1994-04-15
EP0451237B1 (de) 1994-04-06
CA2028629A1 (en) 1991-04-28
US5723146A (en) 1998-03-03
WO1991006284A1 (de) 1991-05-16
DE3936328A1 (de) 1991-05-02
GR900100772A (el) 1992-03-20
HU215127B (hu) 1998-09-28
EP0451237A1 (de) 1991-10-16
JP3011762B2 (ja) 2000-02-21
JPH04503676A (ja) 1992-07-02
PT95697A (pt) 1991-09-13
DE59005281D1 (de) 1994-05-11
NO912435L (no) 1991-06-21
PT95697B (pt) 1997-09-30
FI913100A0 (fi) 1991-06-25

Similar Documents

Publication Publication Date Title
DK634787D0 (da) Topiske farmaceutiske praeparater til behandling af acne
DK0451237T3 (da) Farmaceutiske præparater
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
NO922005D0 (no) Farmasoeytiske preparater
NO910340L (no) Topiske preparater for behandling av menneskenegler.
DK259186D0 (da) Nasale farmaceutiske praeparater
DK522186A (da) Melatoninmaterialer og deres anvendelser
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK296690D0 (da) Topisk, kosmetisk og farmaceutisk praeparat
DE69013557D1 (de) An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK447887D0 (da) Frysetoerrede farmaceutiske praeparater
IT1134458B (it) Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
DK453688A (da) Farmaceutiske praeparater til topisk anvendelse
ES2010963A4 (es) Derivados de n - cicloalkilaminoetilbenzamida, su sintesis y preparacion farmaceutica
FI874643A (fi) Terapeutiska medel och deras anvaendning.
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes
IT1168946B (it) Preparazioni farmaceutiche per trattamento topico della cataratta
PT85350B (de) Xylometazolinhaltige pharmazeutische praeparate
DK326985A (da) Farmaceutiske og kosmetiske praeparater indeholdende et anthracenderivat som aktiv bestanddel
DK645388A (da) Topiske metronidazol-praeparater og terapeutiske anvendelser deraf
ATA256587A (de) Neue cephalosporin-verbindungen sowie diese enthaltende pharmazeutische praeparate
ATE68975T1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
DK587487D0 (da) Veterinaerterapeutiske praeparater